![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Zhejiang Charioteer Pharmaceutical Co., Ltd Xianju Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Clopidogrel hydrogen sulfate, Form I, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2013-015 - Rev 00
This Chemical Type CEP, issued on February 25, 2014, remains in force until July 27, 2017, ensuring its reliability within the pharmaceutical industry.
Substance Number 2531 associated with this CEP further emphasizes